Healthcare Resilience & Clinical Trials in Israel

What is 29C Importation? Regulation 29C governs the importation of non-registered medicinal products into Israel under specific conditions. This regulation allows hospitals, healthcare providers, and sponsors to access treatments that are not locally registered but are essential for patient care. These imports often support clinical trials, compassionate use programs, or off-label treatments when no registered […]

Importing Investigational Medicinal Products (IMPs) and medical supplies for clinical trials is a complex and highly regulated process. Unlike standard commercial imports, clinical trial importation involves unique regulatory and logistical challenges that require specialized expertise. At IMP, we ensure a seamless and compliant importation process, working closely with regulatory authorities, customs officials, and shipping providers […]

In the global landscape of clinical trials, regulatory frameworks vary significantly from one region to another. One of the most critical aspects of these frameworks is the role of the Qualified Person (QP), a function that is mandatory in the European Union but differs considerably in other regions, such as Israel. Understanding these differences is […]